Reustle et al. used patient-derived 3D-ALI cultures of clear cell renal carcinoma (ccRCC) identifying nicotinamide-N-methyltransferase (NNMT) as a potential new therapeutic target [105]. This evidence concerns the gene NNMT and nonpapillary renal cell carcinoma.